Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc. | Financial_Report.xls |
| 10-K/A - UNITED STATES SECURITIES AND EXCHANGE COMMISSION - Q Therapeutics, Inc. | grace25312011_10kz.htm |
| EX-31.2 - EXHIBIT 31 - Q Therapeutics, Inc. | f10ka_ex31z2.htm |
| EX-31.1 - EXHIBIT 31 - Q Therapeutics, Inc. | f10ka_ex31z1.htm |
| EX-32.1 - EXHIBIT 32 - Q Therapeutics, Inc. | f10ka_ex32z1.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Grace 2, Inc. (the “Company”) on Form 10-K for the period ended May 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven J. Borst, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 24, 2011 | By: | /s/ STEVEN J. BORST |
|
| Steven J. Borst, M.B.A. Chief Financial Officer and Vice President of Corporate Development (Principal Financial Officer, Principal Accounting Officer) |
1